Quickly rising SARS-CoV-2 B.1.1.7 sub-lineage in the USA of America with spike protein D178H and membrane protein V70L mutations

 

Summary The SARS-CoV-2 B.1.1.7 lineage is extremely infectious and as of April 2021 accounted for 92% of COVID-19 circumstances in Europe and 59% of COVID-19 circumstances within the U.S. It’s outlined by the N501Y mutation within the receptor binding area (RBD) of the Spike (S) protein, and some different mutations. These embrace two mutations within the N terminal area (NTD) of the S protein, HV69-70del and Y144del (often known as Y145del because of the presence of tyrosine at each positions). We lately recognized a number of rising SARS-CoV-2 variants of considerations, characterised by Membrane (M) protein mutations, together with I82T and V70L. We now determine a sub-lineage of B.1.1.7 that emerged by means of sequential acquisitions of M:V70L in November 2020 adopted by a novel S:D178H mutation first noticed in early February 2021.

 

The proportion of B.1.1.7 isolates within the U.S. that belong to this sub-lineage elevated from 0.15% in February 2021 to 1.8% in April 2021. So far this sub-lineage seems to be U.S.-specific with reported circumstances in 31 states, together with Hawaii. As of April 2021 it constituted 36.8% of all B.1.1.7 isolates in Washington. Phylogenetic evaluation and transmission inference with Nextstrain suggests this sub-lineage possible originated in both California or Washington. Structural evaluation revealed that the S:D178H mutation is within the NTD of the S protein and shut to 2 different signature mutations of B.1.1.7, HV69-70del and Y144del. It’s floor uncovered and will alter NTD tertiary configuration or accessibility, and thus has the potential to have an effect on neutralization by NTD directed antibodies.

 

Speedy three-dimensional form willpower of globular proteins by mobility capillary electrophoresis and native mass spectrometry

Established high-throughput proteomics strategies present restricted data on the stereostructures of proteins. Conventional applied sciences for protein construction willpower sometimes require laborious steps and can’t be carried out in a high-throughput style. Right here, we report a brand new medium throughput methodology by combining mobility capillary electrophoresis (MCE) and native mass spectrometry (MS) for the three-dimensional (3D) form willpower of globular proteins within the liquid section, which offers each the geometric construction and molecular mass data of proteins.

A principle was established to correlate the ion hydrodynamic radius and cost state distribution within the native mass spectrum with protein geometrical parameters, by means of which a low-resolution construction (form) of the protein might be decided. Our take a look at information of 11 completely different globular proteins confirmed that this method permits us to find out the shapes of particular person proteins, protein complexes and proteins in a mix, and to watch protein conformational modifications. Moreover offering complementary protein construction data and having combination evaluation functionality, this MCE and native MS primarily based methodology is quick in velocity and low in pattern consumption, making it probably relevant in top-down proteomics and structural biology for intact globular protein or protein advanced evaluation.

 

Quick floor immobilization of native proteins by means of catalyst-free amino-yne click on bioconjugation

Floor immobilization offers a helpful platform for biosensing, drug screening, tissue engineering and different chemical and organic functions. Nonetheless, a number of the used reactions are inefficient and/or sophisticated, limiting their functions in immobilization. Herein, we use a spontaneous and catalyst-free amino-yne click on bioconjugation to generate activated ethynyl group functionalized surfaces for quick immobilization of native proteins and cells.

Biomolecules, resembling bovine serum albumin (BSA), human IgG and a peptide of C(RGDfK), might be covalently immobilized on the surfaces in as brief as 30 min. Notably, the bioactivity of the anchored biomolecules stays intact, which is verified by effectively capturing goal antibodies and cells from the majority options. This technique represents an alternate for extremely environment friendly floor biofunctionalization.

 

On the binding response of loratadine with human serum acute section protein alpha 1-acid glycoprotein

Loratadine is a crucial anti-allergic drug. It’s a second era antihistamine drug used to deal with allergic rhinitis, hay fever and urticaria. Human serum alpha 1-acid glycoprotein (AG) is a crucial acute section protein and its serum focus is discovered to extend in irritation and acute response.The binding interplay between loratadine and AG is studied utilizing spectroscopy and molecular docking strategies. The outcomes obtained from fluorescence quenching experiments demonstrated that the fluorescence depth of AG is quenched by loratadine. Loratadine was discovered to bind AG with the binding fixed of ≈10⁴ at 298 Ok.

The Gibb’s free power change was discovered to be destructive for the interplay of loratadine with AG indicating the binding course of is spontaneous. Binding of loratadine with AG induced ordered constructions within the protein. Hydrogen bonding and hydrophobic interactions had been the principle bonding forces between AG-loratadine as revealed by molecular docking outcomes. This research suggests the significance of binding of anti-allergic drug to AG spatially within the ailments the place the plasma focus of AG will increase many folds and interplay with this protein turns into important. This research will assist in design of drug dosage and adjustment accordingly to realize optimum therapy consequence. Communicated by Ramaswamy H. Sarma.

Focused Protein Degradation by means of Quick Optogenetic Activation and Its Utility to the Management of Cell Signaling

Improvement of methodologies for optically triggered protein degradation permits the research of dynamic protein capabilities, such as these concerned in cell signaling, which are troublesome to be probed with conventional genetic strategies. Right here, we describe the design and implementation of a novel light-controlled peptide degron conferring N-end pathway degradation to its protein goal. The degron includes a photocaged N-terminal amino acid and a lysine-rich, 13-residue linker. By caging the N-terminal residue, we had been in a position to optically management N-degron recognition by an E3 ligase, consequently controlling ubiquitination and proteasomal degradation of the goal protein.

We reveal broad applicability by making use of this method to a various set of goal proteins, together with EGFP, firefly luciferase, the kinase MEK1, and the phosphatase DUSP6 (often known as MKP3). The caged degron can be utilized with minimal protein engineering and offers nearly full, light-triggered protein degradation on a second to minute time scale.

 

 

Human milk specific allergen antibody(IgE) ELISA Kit
1-CSB-E15859h	Cusabio	Ask for price Ask for price Ask for price	1 plate of 96 wells 10 plates of 96 wells each 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human milk specific allergen antibody(IgE) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human milk specific allergen antibody, IgE ELISA Kit
MBS705693-10x96StripWells	MyBiosource	10x96-Strip-Wells	EUR 5575

Human milk specific allergen antibody, IgE ELISA Kit
MBS705693-24StripWellsLIMIT1	MyBiosource	24-Strip-Wells(LIMIT1)	EUR 275

Human milk specific allergen antibody, IgE ELISA Kit
MBS705693-48StripWells	MyBiosource	48-Strip-Wells	EUR 545

Human milk specific allergen antibody, IgE ELISA Kit
MBS705693-5x96StripWells	MyBiosource	5x96-Strip-Wells	EUR 2920

Human milk specific allergen antibody, IgE ELISA Kit
MBS705693-96StripWells	MyBiosource	96-Strip-Wells	EUR 765

Milk-Specific Proteins, Mouse
MBS6011044-1mL	MyBiosource	1mL	EUR 575

Milk-Specific Proteins, Mouse
MBS6011044-5x1mL	MyBiosource	5x1mL	EUR 2440

Goat anti Rabbit milk proteins
MBS573094-1mL	MyBiosource	1mL	EUR 365

Goat anti Rabbit milk proteins
MBS573094-5x1mL	MyBiosource	5x1mL	EUR 1490

Goat anti Monkey milk proteins
MBS573098-1mL	MyBiosource	1mL	EUR 365

Goat anti Monkey milk proteins
MBS573098-5x1mL	MyBiosource	5x1mL	EUR 1490

Anti-Total Goat Milk Proteins
4042	Cygnus Technologies	1 ml	EUR 400.8
Description: Anti-Total Goat Milk Proteins by Cygnus Technologies is available in Europe via Gentaur.

Anti-Total Goat Milk Proteins
4042-AF	Cygnus Technologies	1 mg	EUR 2295.6
Description: Anti-Total Goat Milk Proteins by Cygnus Technologies is available in Europe via Gentaur.

Anti-Total Goat Milk Proteins
4042-PA	Cygnus Technologies	1 ml	EUR 585.6
Description: Anti-Total Goat Milk Proteins by Cygnus Technologies is available in Europe via Gentaur.

Rabbit anti Mouse milk proteins
MBS573515-1mL	MyBiosource	1mL	EUR 365

Rabbit anti Mouse milk proteins
MBS573515-5x1mL	MyBiosource	5x1mL	EUR 1490

Rabbit anti Human milk proteins
MBS573756-1mL	MyBiosource	1mL	EUR 325

Rabbit anti Human milk proteins
MBS573756-5x1mL	MyBiosource	5x1mL	EUR 1320

Monkey Milk Proteins goat polyclonal antibody, Serum
AP31451SU-N	Origene Technologies GmbH	1 ml	Ask for price

Goat Milk Proteins Antigen Concentrate
F243H	Cygnus Technologies	100 ul	EUR 493.2
Description: Goat Milk Proteins Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur.

Goat Milk Proteins Control Antigen
F247	Cygnus Technologies	50 ul	EUR 308.4
Description: Goat Milk Proteins Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

Milk Proteins, Rhesus Monkey
MBS648458-1mL	MyBiosource	1mL	EUR 575

Milk Proteins, Rhesus Monkey
MBS648458-5x1mL	MyBiosource	5x1mL	EUR 2440

anti- Kv1.4-Specific antibody
FNab04664	FN Test	100µg	EUR 606.3
Description: Antibody raised against Kv1.4-Specific

anti- TUBB3 specific antibody
LSMab09890	Nova Lifetech	100ug	EUR 325

anti- REDD1 specific antibody
FNab07228	FN Test	100µg	EUR 658.5
Description: Antibody raised against REDD1 specific

anti- TDRKH specific antibody
FNab08580	FN Test	100µg	EUR 658.5
Description: Antibody raised against TDRKH specific

anti- TUBB3 specific antibody
FNab09890	FN Test	100µg	EUR 658.5
Description: Antibody raised against TUBB3 specific

Anti-Kv1.4-Specific antibody
PAab04664	Nova Lifetech	100ug	EUR 245

Anti- Ubiquitin Specific Protease 2 (USP2) Human Antibody
GWB-41E623	GenWay Biotech	0.05 mg	Ask for price

Anti- Ubiquitin Specific Protease 4 (USP4) Human Antibody
GWB-4A8EF1	GenWay Biotech	0.05 mg	Ask for price

Anti- Ubiquitin Specific Protease 4 (USP4) Human Antibody
GWB-1A4568	GenWay Biotech	0.05 mg	Ask for price

Placenta Specific Protein 9 (PLAC9) Antibody
20-abx102925	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody
20-abx132127	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 1 mg 200 ug 20 ug 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody
abx236511-100ug	Abbexa	100 ug	EUR 577.2

Placenta Specific Protein 9 (PLAC9) Antibody
20-abx307413	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 1 mg 200 ug 20 ug 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody
20-abx313859	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 1 mg 200 ug 20 ug 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody
abx307413-100g	Abbexa	100 µg	EUR 362.5

Placenta Specific Protein 9 (PLAC9) Antibody
abx307413-20g	Abbexa	20 µg	EUR 162.5

Placenta Specific Protein 9 (PLAC9) Antibody
abx307413-50g	Abbexa	50 µg	EUR 250

Placenta Specific Protein 8 (PLAC8) Antibody
abx236511-100g	Abbexa	100 µg	EUR 350

Placenta Specific Protein 9 (PLAC9) Antibody
abx132127-100tests	Abbexa	100 tests	EUR 300

Placenta Specific Protein 8 (PLAC8) Antibody
abx313859-100g	Abbexa	100 µg	EUR 362.5

Placenta Specific Protein 8 (PLAC8) Antibody
abx313859-20g	Abbexa	20 µg	EUR 162.5

Placenta Specific Protein 8 (PLAC8) Antibody
abx313859-50g	Abbexa	50 µg	EUR 250

Placenta Specific Protein 9 (PLAC9) Antibody
abx102925-100l	Abbexa	100 µl	EUR 287.5

Placenta Specific Protein 9 (PLAC9) Antibody
abx102925-1ml	Abbexa	1 ml	EUR 825

Placenta Specific Protein 9 (PLAC9) Antibody
abx102925-200l	Abbexa	200 µl	EUR 362.5

Anti-TUBB3 Specific Antibody
MBS7607411-01mg	MyBiosource	0.1mg	EUR 330

Anti-TUBB3 Specific Antibody
MBS7607411-5x01mg	MyBiosource	5x0.1mg	EUR 1315

Anti-REDD1 specific antibody
PAab07228	Nova Lifetech	100ug	EUR 275

Anti-TDRKH specific antibody
PAab08580	Nova Lifetech	100ug	EUR 275

Lymphocyte Specific Protein 1 (LSP1) Antibody
20-abx113549	Abbexa	Ask for price Ask for price	150 ul 50 ul

Lymphocyte Specific Protein 1 (LSP1) Antibody
20-abx131687	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Lymphocyte Specific Protein 1 (LSP1) Antibody
20-abx131688	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx146154-100ug	Abbexa	100 ug	EUR 469.2

Lymphocyte Specific Protein 1 (LSP1) Antibody
20-abx014564	Abbexa	Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 200 ug 300 µg

Lymphocyte Specific Protein 1 (LSP1) Antibody
20-abx004294	Abbexa	Ask for price Ask for price Ask for price Ask for price	100 ul 200 ul 20 ul 50 ul

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx234879-100ug	Abbexa	100 ug	EUR 661.2

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx331029-100ul	Abbexa	100 ul	EUR 510

Lymphocyte Specific Protein 1 (LSP1) Antibody
20-abx324055	Abbexa	Ask for price Ask for price	100 ug 50 ug

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx431359-200ul	Abbexa	200 ul	EUR 460.8

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx432939-200ul	Abbexa	200 ul	EUR 460.8

Lymphocyte Specific Protein 1 (LSP1) Antibody
20-abx320072	Abbexa	Ask for price Ask for price	100 ul 50 ul

Lymphocyte Specific Protein 1 Antibody / LSP1
F54824-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: LSP1 / Lymphocyte Specific Protein 1 is an intracellular F-actin binding protein. The protein is expressed in lymphocytes, neutrophils, macrophages, and endothelium and may regulate neutrophil motility, adhesion to fibrinogen matrix proteins, and transendothelial migration. Alternative splicing results in multiple transcript variants encoding different isoforms.

Lymphocyte Specific Protein 1 Antibody / LSP1
F54824-0.4ML	NSJ Bioreagents	0.4 ml	EUR 322.15
Description: LSP1 / Lymphocyte Specific Protein 1 is an intracellular F-actin binding protein. The protein is expressed in lymphocytes, neutrophils, macrophages, and endothelium and may regulate neutrophil motility, adhesion to fibrinogen matrix proteins, and transendothelial migration. Alternative splicing results in multiple transcript variants encoding different isoforms.

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx113549-100l	Abbexa	100 µl	EUR 612.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx234879-100g	Abbexa	100 µg	EUR 350

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx131687-100g	Abbexa	100 µg	EUR 812.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx131687-20g	Abbexa	20 µg	EUR 362.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx131687-5g	Abbexa	5 µg	EUR 287.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx131688-100g	Abbexa	100 µg	EUR 775

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx131688-20g	Abbexa	20 µg	EUR 350

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx131688-5g	Abbexa	5 µg	EUR 275

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx146154-1096tests	Abbexa	10 × 96 tests	Ask for price

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx146154-596tests	Abbexa	5 × 96 tests	Ask for price

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx146154-96tests	Abbexa	96 tests	EUR 337.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx431359-200l	Abbexa	200 µl	EUR 387.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx432939-100g	Abbexa	100 µg	EUR 387.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx324055-100g	Abbexa	100 µg	EUR 250

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx324055-50g	Abbexa	50 µg	EUR 187.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx320072-100l	Abbexa	100 µl	EUR 350

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx320072-50l	Abbexa	50 µl	EUR 237.5

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx014564-100g	Abbexa	100 µg	EUR 43.75

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx004294-100l	Abbexa	100 µl	EUR 400

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx004294-20l	Abbexa	20 µl	EUR 175

Lymphocyte Specific Protein 1 (LSP1) Antibody
abx004294-50l	Abbexa	50 µl	EUR 275

LSP1 Antibody / Lymphocyte Specific Protein 1
V7928-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: LSP1 is a hematopoietic-expressed gene that encodes an F-actin-binding, leukocyte-specific (including B and T lymphocytes, granulocytes and macrophages), phosphoprotein. However, mRNA splice variants that do not encode the lympho-specific protein are expressed from this gene in nonlymphoid cell lines as well (myocytes, stromal cells and fibroblasts), suggesting pp52 has a divergent role in signal transduction. The pp52 (LSP1) locus maps to human chromosome 11p15.5, which is implicated in tumor-related chromosomal translocations found in chronic lymphocytic leukemia. The pp52 promoter contains key elements that control transcriptional activity including an initiator specifying the unique 5' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a single C/EBP motif. LSP1 binds the cytoskeleton and has been implicated in affecting cytoskeletal remodeling in a variety of leukocyte functions, including cell motility and chemotaxis.

LSP1 Antibody / Lymphocyte Specific Protein 1
V7928-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: LSP1 is a hematopoietic-expressed gene that encodes an F-actin-binding, leukocyte-specific (including B and T lymphocytes, granulocytes and macrophages), phosphoprotein. However, mRNA splice variants that do not encode the lympho-specific protein are expressed from this gene in nonlymphoid cell lines as well (myocytes, stromal cells and fibroblasts), suggesting pp52 has a divergent role in signal transduction. The pp52 (LSP1) locus maps to human chromosome 11p15.5, which is implicated in tumor-related chromosomal translocations found in chronic lymphocytic leukemia. The pp52 promoter contains key elements that control transcriptional activity including an initiator specifying the unique 5' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a single C/EBP motif. LSP1 binds the cytoskeleton and has been implicated in affecting cytoskeletal remodeling in a variety of leukocyte functions, including cell motility and chemotaxis.

LSP1 Antibody / Lymphocyte Specific Protein 1
V7928SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: LSP1 is a hematopoietic-expressed gene that encodes an F-actin-binding, leukocyte-specific (including B and T lymphocytes, granulocytes and macrophages), phosphoprotein. However, mRNA splice variants that do not encode the lympho-specific protein are expressed from this gene in nonlymphoid cell lines as well (myocytes, stromal cells and fibroblasts), suggesting pp52 has a divergent role in signal transduction. The pp52 (LSP1) locus maps to human chromosome 11p15.5, which is implicated in tumor-related chromosomal translocations found in chronic lymphocytic leukemia. The pp52 promoter contains key elements that control transcriptional activity including an initiator specifying the unique 5' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a single C/EBP motif. LSP1 binds the cytoskeleton and has been implicated in affecting cytoskeletal remodeling in a variety of leukocyte functions, including cell motility and chemotaxis.

LSP1 Antibody / Lymphocyte Specific Protein 1
V7929-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: LSP1 is a hematopoietic-expressed gene that encodes an F-actin-binding, leukocyte-specific (including B and T lymphocytes, granulocytes and macrophages), phosphoprotein. However, mRNA splice variants that do not encode the lympho-specific protein are expressed from this gene in nonlymphoid cell lines as well (myocytes, stromal cells and fibroblasts), suggesting pp52 has a divergent role in signal transduction. The pp52 (LSP1) locus maps to human chromosome 11p15.5, which is implicated in tumor-related chromosomal translocations found in chronic lymphocytic leukemia. The pp52 promoter contains key elements that control transcriptional activity including an initiator specifying the unique 5' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a single C/EBP motif. LSP1 binds the cytoskeleton and has been implicated in affecting cytoskeletal remodeling in a variety of leukocyte functions, including cell motility and chemotaxis.

LSP1 Antibody / Lymphocyte Specific Protein 1
V7929-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: LSP1 is a hematopoietic-expressed gene that encodes an F-actin-binding, leukocyte-specific (including B and T lymphocytes, granulocytes and macrophages), phosphoprotein. However, mRNA splice variants that do not encode the lympho-specific protein are expressed from this gene in nonlymphoid cell lines as well (myocytes, stromal cells and fibroblasts), suggesting pp52 has a divergent role in signal transduction. The pp52 (LSP1) locus maps to human chromosome 11p15.5, which is implicated in tumor-related chromosomal translocations found in chronic lymphocytic leukemia. The pp52 promoter contains key elements that control transcriptional activity including an initiator specifying the unique 5' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a single C/EBP motif. LSP1 binds the cytoskeleton and has been implicated in affecting cytoskeletal remodeling in a variety of leukocyte functions, including cell motility and chemotaxis.

LSP1 Antibody / Lymphocyte Specific Protein 1
V7929SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: LSP1 is a hematopoietic-expressed gene that encodes an F-actin-binding, leukocyte-specific (including B and T lymphocytes, granulocytes and macrophages), phosphoprotein. However, mRNA splice variants that do not encode the lympho-specific protein are expressed from this gene in nonlymphoid cell lines as well (myocytes, stromal cells and fibroblasts), suggesting pp52 has a divergent role in signal transduction. The pp52 (LSP1) locus maps to human chromosome 11p15.5, which is implicated in tumor-related chromosomal translocations found in chronic lymphocytic leukemia. The pp52 promoter contains key elements that control transcriptional activity including an initiator specifying the unique 5' terminus of pp52 mRNA, tandem pairs of Ets and SP1 motifs, and a single C/EBP motif. LSP1 binds the cytoskeleton and has been implicated in affecting cytoskeletal remodeling in a variety of leukocyte functions, including cell motility and chemotaxis.

Human tumor specific protein 70 (SP70) Antibody
P1058-6ml	SAB	6ml	EUR 381.6

Goat Anti-Human IgG F(ab')2 fragment specific (adsorbed with bovine, horse, mouse serum proteins)
10115-UL	Alpha Diagnostics	0.5 mg	EUR 270

Growth Arrest Specific Protein 2 (GAS2) Antibody
20-abx112854	Abbexa	Ask for price Ask for price	150 ul 50 ul

Growth Arrest Specific Protein 7 (GAS7) Antibody
20-abx112855	Abbexa	Ask for price Ask for price	150 ul 50 ul

Growth Arrest Specific Protein 8 (GAS8) Antibody
20-abx112856	Abbexa	Ask for price Ask for price	150 ul 50 ul

Growth Arrest Specific Protein 2 (GAS2) Antibody
20-abx103339	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Growth Arrest Specific Protein 6 (GAS6) Antibody
20-abx103340	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Growth Arrest Specific Protein 6 (GAS6) Antibody
20-abx103341	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Growth Arrest Specific Protein 6 (GAS6) Antibody
20-abx103342	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Growth Arrest Specific Protein 6 (GAS6) Antibody
20-abx129509	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug

Growth Arrest Specific Protein 6 (GAS6) Antibody
20-abx130151	Abbexa	Ask for price Ask for price Ask for price Ask for price Ask for price	100 ug 10 ug 1 mg 200 ug 50 ug